Events January 14, 2015
Hotel Zetta
55 5th Street
San Francisco, CA

Understanding Biosimilars: Intellectual Property Challenges

Goodwin Procter partners Theresa Kavanaugh, Duncan Greenhalgh, Brian Fairchild, Robert Cerwinski, Elaine Herrmann Blais, and Daryl Wiesen will host this seminar which will address key similarities and differences between the biosimliar pathway and the Hatch-Waxman Act (ANDA) pathway for small molecules, differences in patent strategy for biologics small-molecule and small molecule drugs and biosimilar-specific licensing considerations.